(Q37412922)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279567%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

review article

1 reference

title

A critical appraisal of the safety and efficacy of drug-eluting stents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279567%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279567%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

3

R Waksman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279567%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1

G Maluenda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279567%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

language of work or name

English

0 references

publication date

11 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279567%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279567%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279567%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279567%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

474-480

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279567%20AND%20SRC:MED&resulttype=core&format=json

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Cause of death with bare metal and sirolimus-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Clinical end points in coronary stent trials: a case for standardized definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Stent thrombosis in randomized clinical trials of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Coronary endothelial dysfunction following sirolimus-eluting stent placement: should we worry about it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Occupational allergies caused by latex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Mechanisms of controlled drug release from drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Drug-eluting compared with bare-metal coronary stents among elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Outcomes and complications associated with off-label and untested use of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

Angiographic follow-up after placement of a self-expanding coronary-artery stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

7 January 2021

Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

7 January 2021

Long-term endothelial dysfunction after coronary artery stenting

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

7 January 2021

Background incidence of late malapposition after bare-metal stent implantation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

7 January 2021

Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

7 January 2021

SDZ RAD, a new rapamycin derivative: synergism with cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.8

7 January 2021

Identifiers

DOI

10.1038/CLPT.2009.8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19279567%20AND%20SRC:MED&resulttype=core&format=json

release_zgljxrv4xngi7cug536rpot6oa

23 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zgljxrv4xngi7cug536rpot6oa

24 November 2022

mapped directly with Wikidata item

1 reference